Palantir Bioceuticals

Palantir Bioceuticals FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Palantir Bioceuticals (IFAN) as of Nov 3, 2026 is 28.09 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 293.06 % — a change of -90.41% (lower).

FCF Conversion

28.09 %

YoY

-90.41%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Palantir Bioceuticals is 2015 28.09 % . FCF Conversion Rate (FCF/EBITDA) of Palantir Bioceuticals was 2014 293.06 % . It decreases by -90.41% lower compared to the previous year.

The Palantir Bioceuticals FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2014
293.06 USD
Jan 1, 2015
28.09 USD
The Palantir Bioceuticals FCF Conversion history
YEARFCF ConversionYoY
28.09 %-90.41%
293.06 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Palantir Bioceuticals Stock analysis

What does Palantir Bioceuticals do? IFAN Financial Inc is a company based in Las Vegas, Nevada. It originated in 1998 with the founding of iCARD Systems, specializing in prepaid cards. In 2007, the company changed its name to IFAN Financial Inc and expanded its business. The business model of IFAN Financial Inc focuses on providing financial services and technologies. The company specializes in various fields, including payment processing, mobile payment solutions, e-commerce, point-of-sale systems, and ethical investments. One important division of the company is IFAN Payment Systems, which offers a wide range of payment processing and payment solutions. The solutions can be used both online and offline. One particular feature is that IFAN Payment Systems provides fast transaction processing while maintaining high security standards. IFAN Financial Inc also has a division in the mobile services sector, which includes providing mobile payment solutions and mobile banking services. These services can be accessed through mobile devices and are tailored to the needs of modern customers who use mobile devices to manage and monitor their finances. Another important area in which IFAN Financial Inc operates is e-commerce. The focus is on providing technical solutions that allow customers to securely and effectively buy and sell goods and services online. The company has also developed a solution for online marketplaces, making it easier for merchants to register and sell on multiple platforms. The point-of-sale solutions of IFAN Financial Inc enable secure payments at retail terminals. The company offers a wide range of products, including POS hardware and POS software. These solutions are particularly designed to speed up transaction processing and increase customer satisfaction. Another important aspect of the company is ethical investing. IFAN Financial Inc advocates for ethical investments that have profit-oriented goals but do not come at the expense of other people or the environment. The company identifies investments that align with its portfolio of ethical investment products. Overall, IFAN Financial Inc has a wide portfolio of services and products tailored to the needs of customers. The company strives to provide customers with a secure and effective payment system that helps them manage their finances and optimize their businesses. The company has been in business since 1998 and thus has extensive experience in the financial sector. Palantir Bioceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Palantir Bioceuticals stock

FCF Conversion Rate (FCF/EBITDA) of Palantir Bioceuticals is 28.09 % in 2015.

FCF Conversion Rate (FCF/EBITDA) of Palantir Bioceuticals changed from 293.06 % to 28.09 %, representing a -90.41% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Palantir Bioceuticals since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Palantir Bioceuticals with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Palantir Bioceuticals

All Key Metrics — Palantir Bioceuticals